×
Close
註冊
登入
主页
用户
博客
照片
视频
医学图书S馆
医学图书M馆
医学图书D馆
医学术语
群组
活动
用户工具
用户指南
问答
谁看过我
反馈
语言
English
中文
推广
×
Close
CN1699 Our Business - Guide for Agents
分类
Oncology
56248
Global Medical University
5674
Allergy
1852
Anatomy & Morphology
1618
Andrology
414
Anesthesia & Intensive Care
1355
Anesthesiology
5946
Audiology & Speech-Language Pathology
335
Behavioral Sciences
104
Biochemical Research Methods
7525
Biochemistry & Molecular Biology
31925
Biodiversity Conservation
338
Biology
9151
Biophysics
9605
Biotechnology & Applied Microbiology
9020
Cardiac & Cardiovascular Systems
33475
Cardiovascular & Respiratory Systems
1550
Cell & Tissue Engineering
717
Cell Biology
11579
Chemistry, Analytical
4456
Chemistry, Applied
12018
Chemistry, Medicinal
9087
Chemistry, Multidisciplinary
19808
Clinical Immunology & Infectious Disease
473
Clinical Medicine
9225
Clinical Neurology
17472
Clinical Psychology & Psychiatry
1532
Critical Care Medicine
3487
Dentistry, Oral Surgery & Medicine
14264
Dermatology
7825
Developmental Biology
7346
Ecology
645
Education, Scientific Disciplines
2038
Emergency Medicine
4435
Endocrinology, Metabolism & Nutrition
26147
Engineering, Biomedical
3898
Entomology
457
Environmental Medicine & Public Health
5084
Evolutionary Biology
275
Gastroenterology & Hepatology
12908
General & Internal Medicine
7560
Genetics & Heredity
16211
Geriatrics & Gerontology
5325
Gerontology
350
Health Care Sciences & Services
17107
Health Policy & Services
624
Hematology
5748
Immunology
27341
Infectious Diseases
14863
Integrative & Complementary Medicine
3023
Medical Ethics
1215
Medical Informatics
2447
Medical Laboratory Technology
433
Medicine, General & Internal
47661
Medicine, Legal
549
Medicine, Research & Experimental
19472
Microbiology
25266
Mycology
0
Nanoscience & Nanotechnology
5601
Neuroimaging
1410
Neurology
4904
Neurosciences
43092
Nursing
10019
Nutrition & Dietetics
8245
Obstetrics & Gynecology
8789
Ophthalmology
10594
Optics
4692
Orthopedics
12320
Orthopedics, Rehabilitation & Sports Medicine
1900
Otolaryngology
1617
Otorhinolaryngology
5210
Parasitology
1096
Pathology
5274
Pediatrics
23001
Peripheral Vascular Disease
4948
Pharmacology & Pharmacy
37908
Pharmacology/Toxicology
13324
Physiology
9460
Polymer Science
621
Primary Health Care
863
Psychiatry
21440
Psychology
5409
Psychology, Applied
99
Psychology, Biological
365
Psychology, Clinical
846
Psychology, Developmental
225
Psychology, Educational
149
Psychology, Experimental
137
Psychology, Mathematical
0
Psychology, Multidisciplinary
1629
Psychology, Psychoanalysis
41
Psychology, Social
116
Public Health & Health Care Science
2348
Public, Environmental & Occupational Health
29178
Quantum Science & Technology
0
Radiology, Nuclear Medicine & Imaging
13279
Radiology, Nuclear Medicine & Medical Imaging
8213
Rehabilitation
3129
Remote Sensing
0
Reproductive Biology
3080
Reproductive Medicine
1268
Research/Laboratory Medicine & Medical Technology
4237
Respiratory System
7724
Rheumatology
6354
Social Sciences, Biomedical
1268
Substance Abuse
2855
Surgery
36400
Toxicology
4477
Transplantation
938
Tropical Medicine
314
Urology & Nephrology
13999
Veterinary Sciences
35
Virology
2530
Zoology
0
渠道
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
103
Pathology Society Understanding disease
52
Asian Journal of Oncology
57
Medrxiv - Oncology
997
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
259
BONE MARROW TRANSPLANTATION
876
BREAST CANCER RESEARCH
349
BREAST CANCER RESEARCH AND TREATMENT
816
BRITISH JOURNAL OF CANCER
1141
CA-A CANCER JOURNAL FOR CLINICIANS
24
CANCER
432
CANCER AND METASTASIS REVIEWS
209
CANCER CELL INTERNATIONAL
1040
CANCER DISCOVERY
176
CANCER MEDICINE
476
CANCER PREVENTION RESEARCH
70
CANCER RESEARCH
297
CANCER RESEARCH AND TREATMENT
20
CANCER SCIENCE
256
CANCERS
4437
CLINICAL CANCER RESEARCH
312
CLINICAL EPIGENETICS
499
CURRENT ONCOLOGY REPORTS
429
CURRENT OPINION IN ONCOLOGY
243
CURRENT TREATMENT OPTIONS IN ONCOLOGY
320
EXPERIMENTAL CELL RESEARCH
871
HEMATOLOGICAL ONCOLOGY
172
INTERNATIONAL JOURNAL OF CANCER
292
JOURNAL FOR IMMUNOTHERAPY OF CANCER
1515
JOURNAL OF CANCER
20
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
1183
JOURNAL OF CLINICAL ONCOLOGY
1011
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
902
JOURNAL OF HEMATOLOGY & ONCOLOGY
397
JOURNAL OF NEURO-ONCOLOGY
850
JOURNAL OF PATHOLOGY
39
JOURNAL OF SURGICAL ONCOLOGY
253
LEUKEMIA
890
LIVER CANCER
145
MEDICAL ONCOLOGY
392
MOLECULAR CANCER
550
MOLECULAR CANCER THERAPEUTICS
157
MOLECULAR ONCOLOGY
201
NATURE REVIEWS CANCER
325
NATURE REVIEWS CLINICAL ONCOLOGY
370
NEOPLASIA
289
ONCOGENE
1089
ONCOGENESIS
187
ONCOLOGIST
223
ONCOLOGY-NEW YORK
75
ONCOTARGETS AND THERAPY
610
PSYCHO-ONCOLOGY
175
SURGICAL ONCOLOGY-OXFORD
334
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
166
BMC CANCER
2146
CANCER EPIDEMIOLOGY
431
CANCER GENETICS
31
CANCER MANAGEMENT AND RESEARCH
975
CURRENT ONCOLOGY
816
FRONTIERS IN ONCOLOGY
11165
FUTURE ONCOLOGY
111
GENES CHROMOSOMES & CANCER
58
HEREDITARY CANCER IN CLINICAL PRACTICE
92
INFECTIOUS AGENTS AND CANCER
186
INTEGRATIVE CANCER THERAPIES
69
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
685
JOURNAL OF BUON
11
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
294
JOURNAL OF HEPATOCELLULAR CARCINOMA
421
ONCOLOGY
93
ONCOLOGY RESEARCH AND TREATMENT
164
PEDIATRIC BLOOD & CANCER
403
SEMINARS IN ONCOLOGY NURSING
280
TECHNOLOGY IN CANCER RESEARCH & TREATMENT
204
THORACIC CANCER
271
TUMORI J
67
INDIAN JOURNAL OF CANCER
122
JOURNAL OF ONCOLOGY PRACTICE
436
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
1026
RADIATION ONCOLOGY
565
WORLD CANCER RESEARCH JOURNAL
133
SOUTH ASIAN JOURNAL OF CANCER
300
BREAST CANCER-BASIC AND CLINICAL RESEARCH
23
CANCER REPORTS
184
CASE REPORTS IN ONCOLOGY
358
CLINICAL CANCER INVESTIGATION JOURNAL
10
CURRENT BREAST CANCER REPORTS
122
CURRENT CANCER THERAPY REVIEWS
23
CURRENT COLORECTAL CANCER REPORTS
29
INDIAN JOURNAL OF SURGICAL ONCOLOGY
591
INTERNATIONAL CANCER CONFERENCE JOURNAL
194
INTERNATIONAL JOURNAL OF SURGERY-ONCOLOGY
18
JMIR CANCER
195
JOURNAL OF GASTROINTESTINAL CANCER
425
JOURNAL OF KIDNEY CANCER AND VHL
103
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE
138
RARE TUMORS
23
REHABILITATION ONCOLOGY
110
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY
244
MIDDLE EAST JOURNAL OF CANCER
186
NATURE CANCER
495
ONCOLOGY AND THERAPY
117
ONCOLOGY REVIEWS
17
ONKOLOGIJA
40
HORMONES & CANCER / DISCOVER ONCOLOGY
216
FAMILIAL CANCER
144
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
553
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
80
MEDICAL ONCOLOGY
403
PATHOLOGY & ONCOLOGY RESEARCH
21
PSYCHO-ONCOLOGIE
20
STRAHLENTHERAPIE UND ONKOLOGIE
419
SUPPORTIVE CARE IN CANCER
1381
TARGETED ONCOLOGY
239
SCI时时刷
search
全部
推荐
+
Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinion
Cutaneous squamous cell carcinoma (CSCC) is the second most common skin malignancy in white-skinned populations. Only a mi...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines
Background:Evidence to date supports continued human epidermal growth factor receptor 2 (HER2) suppression beyond progress...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Predicting treatment outcomes using 18F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy
Background:Predictive markers for treatment response and survival outcome have not been identified in patients with advanc...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial
Background:FOLFIRI [irinotecan, folinic acid (CF), and fluorouracil] is considered a standard second-line chemotherapy reg...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study
Background:Perioperative chemotherapy is a recommended treatment approach for localised oesophago-gastric junction adenoca...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients: clinical and translational analysis
Background:Primary breast cancer (BC) has shown a higher immune infiltration than the metastatic disease, justifying the o...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy
Background:A reliable model is needed to estimate the risk of postoperative recurrence and the benefits of postoperative r...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Retraction notice: Downregulation of long noncoding RNA LINC01419 inhibits cell migration, invasion, and tumor growth and promotes autophagy via inactivation of the PI3K/Akt1/mTOR pathway in gastric cancer.
Access to society journal content varies across our titles. If you have access to a journal via a society or association ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)
Background:Standard intravenous (IV) paclitaxel is associated with hypersensitivity/toxicity. Alternative IV formulations ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment
Due to occupational asbestosis exposure, the incidence of malignant pleural mesothelioma (MPM) has continuously increased ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1/2 mutations and hormone receptor status from the phase-3 BROCADE3 trial
Purpose:To evaluate efficacy and safety of veliparib combined with carboplatin/paclitaxel in patients with advanced human ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells?
Access to society journal content varies across our titles. If you have access to a journal via a society or association ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Correction notice to “Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model”
Chiao-Fang TengGraduate Institute of Biomedical Sciences, China Medical University, No.91, Hsueh-Shih Rd., Northern Dist....
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT)
Introduction:For epidermal growth factor receptor mutation-positive (EGFRm) non-small-cell lung cancer (NSCLC), EGFR-tyros...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
A novel event-free survival endpoint in locally advanced pancreatic cancer
The treatment paradigm for locally advanced pancreatic cancer (LAPC) is evolving rapidly. The development of neoadjuvant t...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Surrogate endpoints for early-stage breast cancer: a review of the state of the art, controversies, and future prospects
Drug approval for early-stage breast cancer (EBC) has been historically granted in the context of registration trials base...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting
Background:The evolution of therapeutic landscape of human epidermal growth factor receptor-2 (HER2)-positive breast cance...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Novel emerging biomarkers to immunotherapy in kidney cancer
The treatment of metastatic renal cell carcinoma has significantly evolved in recent years, particularly with the advent o...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer
Background:Ovarian cancer (OvCa) constitutes a rare and highly aggressive malignancy and is one of the most lethal of all ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study
Background:Liposomal irinotecan (nal-IRI) plus 5-fluorouracil and leucovorin (5-FU/LV) is currently the standard second-li...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Phase III double-blind study comparing the efficacy and safety of proposed biosimilar MYL-1402O and reference bevacizumab in stage IV non-small-cell lung cancer
Purpose:This phase III study compared the efficacy and safety of proposed biosimilar MYL-1402O with reference bevacizumab ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer
Background:Adjuvant platinum-based chemotherapy is standard of care for patients with resected stage IIA/B or IIIA NSCLC. ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial
Background:The aim of this study was to evaluate the efficacy and safety of gemcitabine plus nab-paclitaxel (GnP) as secon...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Comprehensive analysis of prognostic value of lymph node classifications in esophageal squamous cell carcinoma: a large real-world multicenter study
Background:We aim to assess the prognostic ability of three common lymph node–based staging algorithms, namely, the number...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
Background:Cancer patients are at higher risk of COVID-19 complications and mortality than the rest of the population. Bre...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Minibeam radiation therapy enhanced tumor delivery of PEGylated liposomal doxorubicin in a triple-negative breast cancer mouse model
Background:Minibeam radiation therapy is an experimental radiation therapy utilizing an array of parallel submillimeter pl...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Development of a risk classification system combining TN-categories and circulating EBV DNA for non-metastatic NPC in 10,149 endemic cases
Background:The objective of this study was to construct a risk classification system integrating cell-free Epstein-Barr vi...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mutational profile for the differential diagnosis with primary mucinous ovarian carcinoma
Background:Ovarian metastases (OM) of pancreatic adenocarcinoma (PA) (OM-PA) can mimic primary ovarian mucinous carcinoma ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?
Prostate-specific membrane antigen (PSMA) is highly expressed on the membrane of most prostate cancer cells and to a lesse...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
A case of advanced adenocarcinoma genetically confirmed with EGFR/BRAF co-mutation in both primary and metastatic lesions
Driver mutations in lung cancer have been generally considered mutually exclusive; however, multiple gene screenings have ...
Therapeutic Advances In Medical Oncology
comment
0
thumb_up
0
阅读更多
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin